Exicure (XCUR) Equity Average (2017 - 2026)
Exicure (XCUR) reported Equity Average of $3.0 million for Q1 2026, down 66.82% on a YoY basis from $9.1 million in Q1 2025, and down 44.49% quarter-over-quarter from $5.4 million in Q4 2025.
Exicure (XCUR) Equity Average (2017 - 2026) Analysis & Trends
Exicure has reported Equity Average for 10 years, with the latest figure at $3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average fell 66.82% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (down 66.82% YoY), and the FY2025 full-year result was $5.3 million, up 9.13% from the prior year.
- Equity Average for Q1 2026 stood at $3.0 million, down from $5.4 million in the prior quarter.
- The five-year high for Equity Average was $14.8 million in Q1 2023, with the low at -$1.3 million in Q3 2022.
- Historically, Equity Average has averaged $5.7 million across 5 years, with a median of $5.4 million in 2025.
- Annual changes were most pronounced in 2022 — Equity Average slumped 105.02% — and 2023, when it surged 659.17%.
- Exicure's Equity Average stood at $5.6 million in 2022, then slumped by 32.89% to $3.8 million in 2023, then rose by 10.47% to $4.2 million in 2024, then jumped by 30.49% to $5.4 million in 2025, then tumbled by 44.49% to $3.0 million in 2026.
- The last three Equity Average figures came in at $3.0 million (Q1 2026), $5.4 million (Q4 2025), and $7.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 516.41 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 3.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.01 Mn |
| Dec 31, 2025 | 5.43 Mn |
| Sep 30, 2025 | 7.90 Mn |
| Jun 30, 2025 | 10.12 Mn |
| Mar 31, 2025 | 9.08 Mn |
| Dec 31, 2024 | 4.16 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 3.76 Mn |
| Sep 30, 2023 | 7.10 Mn |
| Jun 30, 2023 | 12.16 Mn |
| Mar 31, 2023 | 14.77 Mn |
| Dec 31, 2022 | 5.61 Mn |
| Sep 30, 2022 | -1.27 Mn |
| Jun 30, 2022 | 2.20 Mn |
| Mar 31, 2022 | 7.23 Mn |
| Dec 31, 2021 | 12.61 Mn |
| Sep 30, 2021 | 25.31 Mn |
| Jun 30, 2021 | 43.34 Mn |